MediciNova Inc. (MNOV)
MediciNova Statistics
Share Statistics
MediciNova has 49.05M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 49.05M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 10.05% |
| Shares Floating | 46.48M |
| Failed to Deliver (FTD) Shares | 128 |
| FTD / Avg. Volume | 0.38% |
Short Selling Information
The latest short interest is 182.2K, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 182.2K |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.39% |
| Short Ratio (days to cover) | 11.2 |
Valuation Ratios
The PE ratio is -8.58 and the forward PE ratio is -3.96. MediciNova's PEG ratio is 0.21.
| PE Ratio | -8.58 |
| Forward PE | -3.96 |
| PS Ratio | 73.57 |
| Forward PS | 79.5 |
| PB Ratio | 1.18 |
| P/FCF Ratio | -9.87 |
| PEG Ratio | 0.21 |
Enterprise Valuation
MediciNova Inc. has an Enterprise Value (EV) of 22.79M.
| EV / Earnings | -2.66 |
| EV / Sales | 22.79 |
| EV / EBITDA | -2.31 |
| EV / EBIT | -2.3 |
| EV / FCF | -3.06 |
Financial Position
The company has a current ratio of 15.61, with a Debt / Equity ratio of 0.
| Current Ratio | 15.61 |
| Quick Ratio | 15.61 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.34 |
| Cash Flow / Debt | -34.41 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.14% and return on capital (ROIC) is -15.82%.
| Return on Equity (ROE) | -0.14% |
| Return on Assets (ROA) | -0.13% |
| Return on Capital (ROIC) | -15.82% |
| Revenue Per Employee | $76,923.08 |
| Profits Per Employee | $-659,347.38 |
| Employee Count | 13 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 3.05K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 20% in the last 52 weeks. The beta is 0.82, so MediciNova's price volatility has been higher than the market average.
| Beta | 0.82 |
| 52-Week Price Change | 20% |
| 50-Day Moving Average | 1.95 |
| 200-Day Moving Average | 1.7 |
| Relative Strength Index (RSI) | 33.74 |
| Average Volume (20 Days) | 33.9K |
Income Statement
In the last 12 months, MediciNova had revenue of 1M and earned -8.57M in profits. Earnings per share was -0.17.
| Revenue | 1M |
| Gross Profit | 1M |
| Operating Income | -9.9M |
| Net Income | -8.57M |
| EBITDA | -9.88M |
| EBIT | -9.9M |
| Earnings Per Share (EPS) | -0.17 |
Balance Sheet
The company has 51M in cash and 215.93K in debt, giving a net cash position of 50.78M.
| Cash & Cash Equivalents | 51M |
| Total Debt | 215.93K |
| Net Cash | 50.78M |
| Retained Earnings | -415.7M |
| Total Assets | 58.12M |
| Working Capital | 40.67M |
Cash Flow
In the last 12 months, operating cash flow was -7.43M and capital expenditures -21.3K, giving a free cash flow of -7.45M.
| Operating Cash Flow | -7.43M |
| Capital Expenditures | -21.3K |
| Free Cash Flow | -7.45M |
| FCF Per Share | -0.15 |
Margins
Gross margin is 100%, with operating and profit margins of -990.03% and -857.15%.
| Gross Margin | 100% |
| Operating Margin | -990.03% |
| Pretax Margin | -856.85% |
| Profit Margin | -857.15% |
| EBITDA Margin | -988% |
| EBIT Margin | -990.03% |
| FCF Margin | -745.23% |
Dividends & Yields
MNOV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -10.49% |
| FCF Yield | -9.38% |
Analyst Forecast
The average price target for MNOV is $9, which is 455.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $9 |
| Price Target Difference | 455.6% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | -10212.39 |
| Piotroski F-Score | 1 |